Cline Scientific AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLINE-B.ST research report →
Companywww.clinescientific.com
Cline Scientific AB (publ) develops cancer diagnostics and regenerative medicine treatments in Sweden. It develops an allogenic stem cell therapy based on induced pluripotent stem (iPS) cells. The company also develops surface nanotechnology for cell-based products and processes to drive projects within life science into the clinical phase.
- CEO
- Anders Patrik Sundh
- IPO
- 2015
- Employees
- 2
- HQ
- Mölndal, SE
Price Chart
Valuation
- Market Cap
- $3.11M
- P/E
- -0.66
- P/S
- 0.74
- P/B
- 0.10
- EV/EBITDA
- -0.18
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 97.72%
- Op Margin
- -74.02%
- Net Margin
- -74.95%
- ROE
- -16.76%
- ROIC
- -14.86%
Growth & Income
- Revenue
- $4.20M · 44.83%
- Net Income
- $-3,147,972 · -33.76%
- EPS
- $-0.10 · -1.01%
- Op Income
- $-3,108,861
- FCF YoY
- -5.30%
Performance & Tape
- 52W High
- $0.18
- 52W Low
- $0.06
- 50D MA
- $0.07
- 200D MA
- $0.08
- Beta
- 0.37
- Avg Volume
- 0
Get TickerSpark's AI analysis on CLINE-B.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CLINE-B.ST Coverage
We haven't published any research on CLINE-B.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLINE-B.ST Report →